Nexgel (NXGL) EPS (Diluted) Growth (3y) (2021 - 2025)
Nexgel (NXGL) EPS (Diluted) Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 371.81% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 24.56% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -38.15% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 20.15% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 1.38% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -58.73% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -64.79% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.40% |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 | -0.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.55% |
| Sep 30, 2025 | -617.00% |
| Jun 30, 2025 | 23.36% |
| Mar 31, 2025 | 35.44% |
| Dec 31, 2024 | 40.22% |
| Sep 30, 2024 | 33.10% |
| Jun 30, 2024 | 17.72% |
| Mar 31, 2024 | 14.85% |
| Dec 31, 2023 | 18.86% |
| Sep 30, 2023 | 23.93% |
| Jun 30, 2023 | 92.24% |
| Mar 31, 2023 | 91.94% |
| Dec 31, 2022 | 55.75% |
| Sep 30, 2022 | 93.54% |
| Mar 31, 2022 | 57.46% |
| Dec 31, 2021 | 71.88% |
| Sep 30, 2021 | 58.26% |